Ayurvedic management of Epilepsy in childre
Phase 3
- Conditions
- Health Condition 1: G409- Epilepsy, unspecified
- Registration Number
- CTRI/2023/03/050961
- Lead Sponsor
- Dr Suryanarayana Mudadla
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Children aged between 1 to 16 years diagnosed with epilepsy With ongoing medication of Valproic acid and having more than 2 episodes in the past 3 months will be included in the present study irrespective of types of epilepsy will be included for the present study
Exclusion Criteria
1. Childhood epilepsy with acute seizures, multiple seizures >3/day, status epileptics, and associated with any neurodegenerative disorders like SSPE, NCL, Ataxic ataxia telangiectasia, MND will be excluded from the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method If Ayurvedic interventions along with antiepileptic drugs in the management of epilepsy found to be more efficacious then the same treatment plan will be studied in the management febrile complex seizures, neonatal seizures and all other seizure disordersTimepoint: Subjective parameters will be assessed on Day 1 (before treatment), day 30, 60th day, 90th day and 180th) day (after follow up). <br/ ><br>EEG before treatment (day 1 to past 3 months reports) and after follow up (3 months) <br/ ><br>
- Secondary Outcome Measures
Name Time Method COGNITIVE SKILLS WILL BE ASSESSED AS SECONDARY OUTCOMETimepoint: IMPROVEMENT IN THE COGNITIVE SKILLS WILL BE MEASURED BY APPROPRIATE SCALES ON BASLINE ,DURING TREATMENT ON 45TH DAY AND AFTER THE TREATMENT ON 90TH DAY